ENZYMICALS AG
The focus of the independent SME Enzymicals AG (ENZY) is the development and production of enzymes, the chemo-biocatalytic synthesis of fine and specialty chemicals as well as the development, scale up and piloting of robust chemo-biocatalytic processes. These core areas are combined to realize tailor-made solutions for custom development and manufacturing. Enzymicals has a technology platform which covers the identification of suitable catalysts from strain or enzyme collections, databases ormetagenome libraries as well as their functional expression in a range of microbial host systems. Additionally, Enzymicals has in-house capability for tailor-made protein expression and optimization services. With these facilities almost any biocatalyst of interest can be supplied in analytical and commercial scale. Enzymicals has experience in working with innovative biocatalysts from the class of e.g. transaminases, monooxygenases, halohydrin dehalogenases, imine reductases and hydrolases at desired quality grades to solve customer specific demands at best performance.
Dedicated to design, develop and implement innovative cost-effective and scalable chemo-biocatalytic routes to fine chemicals & APIs, Enzymicals offers recognized expertise in the use of enzymatic processes for complex chemical synthesis.
